Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Gastroenterology & Hepatology
|
October 1, 2011
Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy
Arie Regev
Seminars in Liver Disease
|
June 1, 2014
Drug-induced liver injury and drug development: industry perspective
Arie Regev
Clinics in Liver Disease
|
October 9, 2013
How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval
Arie Regev
Gastroenterology
|
November 6, 2016
Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?
Naga Chalasani, Arie Regev
Medgenmed : Medscape General Medicine
|
August 24, 2006
Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management
Ian Schreibman, Arie Regev
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 1, 2006
Atypical giant hepatic hemangiomas with intratumoral hemorrhage
Paul A Feldman, Arie Regev
Gastroenterology
|
June 1, 2014
Drug-induced liver injury: morbidity, mortality, and Hy's law
Arie Regev, Einar S Björnsson
Scandinavian Journal of Gastroenterology
|
September 14, 2007
Laparoscopic observations of the liver in hereditary hemorrhagic telangiectasia
Wojciech Blonski, Arie Regev, K Rajender Reddy
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 4, 2012
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list
Laurence S Magder, Arie Regev, Ayse L Mindikoglu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 7, 2005
Epithelioid hemangioendothelioma of the liver
Ayse L Mindikoglu, Arie Regev, Eugene R Schiff
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Gastroenterology & Hepatology
|
October 1, 2011
Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy
Arie Regev
Seminars in Liver Disease
|
June 1, 2014
Drug-induced liver injury and drug development: industry perspective
Arie Regev
Clinics in Liver Disease
|
October 9, 2013
How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval
Arie Regev
Gastroenterology
|
November 6, 2016
Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?
Naga Chalasani, Arie Regev
Medgenmed : Medscape General Medicine
|
August 24, 2006
Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management
Ian Schreibman, Arie Regev
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 1, 2006
Atypical giant hepatic hemangiomas with intratumoral hemorrhage
Paul A Feldman, Arie Regev
Gastroenterology
|
June 1, 2014
Drug-induced liver injury: morbidity, mortality, and Hy's law
Arie Regev, Einar S Björnsson
Scandinavian Journal of Gastroenterology
|
September 14, 2007
Laparoscopic observations of the liver in hereditary hemorrhagic telangiectasia
Wojciech Blonski, Arie Regev, K Rajender Reddy
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 4, 2012
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list
Laurence S Magder, Arie Regev, Ayse L Mindikoglu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 7, 2005
Epithelioid hemangioendothelioma of the liver
Ayse L Mindikoglu, Arie Regev, Eugene R Schiff
Page
of 7